1154740-52-9

Basic information

• Product Name: 3-chloro-2-(3-hydroxypropyl)phenol.
• Synonyms: 3-chloro-2-(3-hydroxypropyl)phenol.
• CAS NO: 1154740-52-9
• Molecular Weight: 186.638
• Mol File: 1154740-52-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-chloro-2-(3-hydroxypropyl)phenol.(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-2-(3-hydroxypropyl)phenol.(1154740-52-9)
• EPA Substance Registry System: 3-chloro-2-(3-hydroxypropyl)phenol.(1154740-52-9)

Safety Data

• Hazardous Substances Data: 1154740-52-9(Hazardous Substances Data)

Upstream product

• 1154740-51-8 3-chloro-2-(3-hydroxypropyl)phenyl diethylcarbamate. 
• 159390-33-7 3-chlorophenyl N,N-diethylcarbamate 
• 1154740-50-7 C₁₄H₁₆ClNO₃ 
• 108-43-0 3-monochlorophenol 
• 863870-77-3 3-chloro-2-iodophenyl N,N-dimethyl O-carbamate 

Relevant articles and documents

THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS

The present invention relates to a series of compounds of formula (A) having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having anti-viral activity.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula (I): wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

The present invention relates to compounds of formula (I) wherein c, X, Y, R2, R3, R4 and R6 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection